{"id":"W3189793200","doi":"10.1056/nejmoa2105911","title":"Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1072,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Health Research Council of New Zealand; National Health and Medical Research Council; Medical Research Council; FP7 Health; University of Pittsburgh; Medical Center, University of Pittsburgh; National Institutes of Health; Minderoo Foundation; Eisai; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute for Health and Care Research; European Commission; Breast Cancer Research Foundation; NIHR Imperial Biomedical Research Centre; Amgen; National Center for Advancing Translational Sciences; Wellcome Trust","keywords":"Heparin; Critically ill; Anticoagulant; Respiratory failure; Thrombosis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}